Skip to main content

Table 5 The PPV of NIPT for fetal SCAs with different prenatal diagnosis indications

From: The application of NIPT using combinatorial probe-anchor synthesis to identify sex chromosomal aneuploidies (SCAs) in a cohort of 570 pregnancies

Sex chromosomal aneuploidies

Prenatal diagnostic indications

True positive rate(%)(Amniocentesis/ NIPT)

Types

advanced maternal age

others

serological screening high/ critical risk value

45,X

45.45(5/11)

25.00(2/8)

–

47,XXY

72.73(8/11)

100.00(1/1)

–

47,XYY

50.00 (1/2)

— (0/0)

–

47,XXX

100.00(7/7)

100.00(2/2)

0.00(0/1)

Total

67.74(21/31)

45.45(5/11)

0.00(0/1)